Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia (NCT07686263)

🧪 Interventions in This Study

• Xanomeline/Trospium Chloride (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (61 Sites)

Showing the first 25 of 61 sites.

• Local Institution - 0133 — Bentonville, Arkansas
• Local Institution - 0154 — Bentonville, Arkansas
• Local Institution - 0139 — Little Rock, Arkansas
• Local Institution - 0021 — Little Rock, Arkansas
• Local Institution - 0153 — Rogers, Arkansas
• Local Institution - 0190 — Anaheim, California
• Local Institution - 0040 — Bellflower, California
• Local Institution - 0188 — Chino, California
• Local Institution - 0032 — Culver City, California
• Local Institution - 0037 — Garden Grove, California
• Local Institution - 0068 — La Habra, California
• Local Institution - 0128 — Lemon Grove, California
• Local Institution - 0187 — Montclair, California
• Local Institution - 0151 — Orange, California
• Local Institution - 0030 — Pico Rivera, California
• Local Institution - 0185 — Redlands, California
• Local Institution - 0186 — Riverside, California
• Local Institution - 0149 — Hollywood, Florida
• Local Institution - 0145 — Hollywood, Florida
• Local Institution - 0075 — Miami, Florida
• Local Institution - 0054 — Miami Lakes, Florida
• Local Institution - 0134 — Miami Springs, Florida
• Local Institution - 0044 — West Palm Beach, Florida
• Local Institution - 0166 — Atlanta, Georgia
• Local Institution - 0070 — Sandy Springs, Georgia

📞 Contact the Study Coordinator

Phone: (855) 907-3286

Email: Clinical.Trials@bms.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Schizophrenia

• Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
• Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
• Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
• Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
• Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario
• Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia — Suwanee, Georgia

Explore by condition: All Schizophrenia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.